Abivax S.A.
AAVXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $448,712 | $481,568 | $120,589 | $471,512 |
| - Cash | $144,221 | $251,942 | $26,944 | $60,695 |
| + Debt | $97,361 | $58,973 | $46,721 | $53,446 |
| Enterprise Value | $401,852 | $288,599 | $140,366 | $464,263 |
| Revenue | $10,792 | $4,621 | $4,583 | $37 |
| % Growth | 133.5% | 0.8% | 12,286.5% | – |
| Gross Profit | $10,792 | $4,493 | $4,512 | -$119 |
| % Margin | 100% | 97.2% | 98.5% | -321.6% |
| EBITDA | -$171,883 | -$133,207 | -$53,315 | -$38,738 |
| % Margin | -1,592.7% | -2,882.6% | -1,163.3% | -104,697.3% |
| Net Income | -$176,242 | -$147,740 | -$69,846 | -$41,357 |
| % Margin | -1,633.1% | -3,197.1% | -1,524% | -111,775.7% |
| EPS Diluted | -2.8 | -3.43 | -3.13 | -2.47 |
| % Growth | 18.4% | -9.6% | -26.7% | – |
| Operating Cash Flow | -$154,072 | -$97,130 | -$65,579 | -$45,657 |
| Capital Expenditures | -$643 | -$265 | -$3,968 | -$1,642 |
| Free Cash Flow | -$154,715 | -$97,395 | -$69,547 | -$47,299 |